Theyre available in English and Spanish
Who should not take GLP-1s GLP-1s in all forms are unsuitable for people who: are pregnant or breastfeeding do not meet the eligibility criteria have a family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) Medical Perspective Patients with needle phobia, a preference for pill-based routines, or good adherence to oral administration guidelines may be better suited to oral GLP-1 formulations like semaglutide (Rybelsus, Wegovy), which can enhance treatment acceptance and potentially offer strong glycemic or weight control
Additionally, the potential for side effects, interactions with other medications, and the individuals response to treatment should all be considered
Alternative therapies may be more appropriate depending on individual risk factors and treatment goals
Learn more about menopause treatment Perimenopause treatments Hormonal changes often begin years before menopause
Today, that approach is far less reliable